Irinotecan disrupts tight junction proteins within the gut

References

• Keefe DM, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47:632 - 7; http://dx.doi.org/10.1136/gut.47.5.632; PMID: 11034578
   PubMed Web of Science ®Google Scholar
• Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003; 98:1531 - 9; http://dx.doi.org/10.1002/cncr.11671; PMID: 14508842
   PubMed Web of Science ®Google Scholar
• Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007; 109:820 - 31; http://dx.doi.org/10.1002/cncr.22484; PMID: 17236223
   PubMed Web of Science ®Google Scholar
• Sonis ST. Oral mucositis in cancer therapy. J Support Oncol 2004; 2:Suppl 3 3 - 8; PMID: 15605918
   PubMedGoogle Scholar
• Sonis ST. A biological approach to mucositis. J Support Oncol 2004; 2:21 - 32, discussion 35-6; PMID: 15330370
   PubMedGoogle Scholar
• Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004; 4:277 - 84; http://dx.doi.org/10.1038/nrc1318; PMID: 15057287
   PubMed Web of Science ®Google Scholar
• Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther 2008; 7:1139 - 45; http://dx.doi.org/10.4161/cbt.7.7.6207; PMID: 18535404
   PubMed Web of Science ®Google Scholar
• Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Keefe DM. Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats. Cancer Biol Ther 2008; 7:1919 - 25; http://dx.doi.org/10.4161/cbt.7.12.6940; PMID: 18927500
   PubMed Web of Science ®Google Scholar
• Al-Dasooqi N, Gibson RJ, Bowen JM, Logan RM, Stringer AM, Keefe DM. Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat. Exp Biol Med (Maywood) 2010; 235:1244 - 56; http://dx.doi.org/10.1258/ebm.2010.010082; PMID: 20682600
   PubMed Web of Science ®Google Scholar
• Wardill HR, Bowen JM, Gibson RJ. Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal?. Cancer Chemother Pharmacol 2012; 70:627 - 35; http://dx.doi.org/10.1007/s00280-012-1989-5; PMID: 23053271
   PubMed Web of Science ®Google Scholar
• Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108:1566 - 81; http://dx.doi.org/10.1016/0016-5085(95)90708-4; PMID: 7729650
   PubMed Web of Science ®Google Scholar
• Cummins PM. Occludin: one protein, many forms. Mol Cell Biol 2012; 32:242 - 50; http://dx.doi.org/10.1128/MCB.06029-11; PMID: 22083955
   PubMed Web of Science ®Google Scholar
• González-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 2008; 1778:729 - 56; http://dx.doi.org/10.1016/j.bbamem.2007.08.018; PMID: 17950242
   PubMed Web of Science ®Google Scholar
• Shin K, Margolis B. ZOning out tight junctions. Cell 2006; 126:647 - 9; http://dx.doi.org/10.1016/j.cell.2006.08.005; PMID: 16923383
   PubMed Web of Science ®Google Scholar
• Will C, Fromm M, Müller D. Claudin tight junction proteins: novel aspects in paracellular transport. Perit Dial Int 2008; 28:577 - 84; PMID: 18981384
   PubMed Web of Science ®Google Scholar
• Bertiaux-Vandaële N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, Leroi AM, Déchelotte P, Ménard JF, Ducrotté P, et al. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Am J Gastroenterol 2011; 106:2165 - 73; http://dx.doi.org/10.1038/ajg.2011.257; PMID: 22008894
   PubMed Web of Science ®Google Scholar
• Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, Richter J, Bojarski C, Schumann M, Fromm M. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci 2009; 1165:294 - 300; http://dx.doi.org/10.1111/j.1749-6632.2009.04062.x; PMID: 19538319
   PubMed Web of Science ®Google Scholar
• Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9:799 - 809; http://dx.doi.org/10.1038/nri2653; PMID: 19855405
   PubMed Web of Science ®Google Scholar
• McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, Schneeberger EE. Occludin is a functional component of the tight junction. J Cell Sci 1996; 109:2287 - 98; PMID: 8886979
   PubMed Web of Science ®Google Scholar
• Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 2011; 141:769 - 76; http://dx.doi.org/10.3945/jn.110.135657; PMID: 21430248
   PubMed Web of Science ®Google Scholar
• Schulzke JD, Gitter AH, Mankertz J, Spiegel S, Seidler U, Amasheh S, Saitou M, Tsukita S, Fromm M. Epithelial transport and barrier function in occludin-deficient mice. Biochim Biophys Acta 2005; 1669:34 - 42; http://dx.doi.org/10.1016/j.bbamem.2005.01.008; PMID: 15842997
   PubMed Web of Science ®Google Scholar
• Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000; 11:4131 - 42; http://dx.doi.org/10.1091/mbc.11.12.4131; PMID: 11102513
   PubMed Web of Science ®Google Scholar
• Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE. Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci (Lond) 1997; 92:385 - 9; PMID: 9176038
   PubMed Web of Science ®Google Scholar
• Blijlevens NM, Donnelly JP, de Pauw BE. Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant. Bone Marrow Transplant 2005; 35:707 - 11; http://dx.doi.org/10.1038/sj.bmt.1704863; PMID: 15785771
   PubMed Web of Science ®Google Scholar
• Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Burns J, Keefe DM. Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat. Exp Biol Med (Maywood) 2007; 232:96 - 106; PMID: 17202590
   PubMed Web of Science ®Google Scholar
• Fish SM, Proujansky R, Reenstra WW. Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function. Gut 1999; 45:191 - 8; http://dx.doi.org/10.1136/gut.45.2.191; PMID: 10403730
   PubMed Web of Science ®Google Scholar
• Muza-Moons MM, Schneeberger EE, Hecht GA. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells. Cell Microbiol 2004; 6:783 - 93; http://dx.doi.org/10.1111/j.1462-5822.2004.00404.x; PMID: 15236645
   PubMed Web of Science ®Google Scholar
• Nakao T, Kurita N, Komatsu M, Yoshikawa K, Iwata T, Utusnomiya T, Shimada M. Irinotecan injures tight junction and causes bacterial translocation in rat. J Surg Res 2012; 173:341 - 7; http://dx.doi.org/10.1016/j.jss.2010.10.003; PMID: 21176921
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:e45; http://dx.doi.org/10.1093/nar/29.9.e45; PMID: 11328886
   PubMed Web of Science ®Google Scholar
• Gibson RJ, Keefe DM. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer 2006; 14:890 - 900; http://dx.doi.org/10.1007/s00520-006-0040-y; PMID: 16604351
   PubMed Web of Science ®Google Scholar
• Bowen JM, Elad S, Hutchins RD, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update. Support Care Cancer 2013; 21:303 - 8; http://dx.doi.org/10.1007/s00520-012-1592-7; PMID: 22960942
   PubMed Web of Science ®Google Scholar
• Amasheh M, Grotjohann I, Amasheh S, Fromm A, Söderholm JD, Zeitz M, Fromm M, Schulzke JD. Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol 2009; 44:1226 - 35; http://dx.doi.org/10.1080/00365520903131973; PMID: 19658020
   PubMed Web of Science ®Google Scholar
• Bürgel N, Bojarski C, Mankertz J, Zeitz M, Fromm M, Schulzke JD. Mechanisms of diarrhea in collagenous colitis. Gastroenterology 2002; 123:433 - 43; http://dx.doi.org/10.1053/gast.2002.34784; PMID: 12145796
   PubMed Web of Science ®Google Scholar
• Amasheh S, Meiri N, Gitter AH, Schöneberg T, Mankertz J, Schulzke JD, Fromm M. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 2002; 115:4969 - 76; http://dx.doi.org/10.1242/jcs.00165; PMID: 12432083
   PubMed Web of Science ®Google Scholar
• Carneiro-Filho BA, Lima IP, Araujo DH, Cavalcante MC, Carvalho GH, Brito GA, Lima V, Monteiro SM, Santos FN, Ribeiro RA, et al. Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig Dis Sci 2004; 49:65 - 72; http://dx.doi.org/10.1023/B:DDAS.0000011604.45531.2c; PMID: 14992437
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang L, Lin XY, Wang J, Yu JH, Miao Y, Wang EH. Anti-apoptotic effect of claudin-1 on TNF-α-induced apoptosis in human breast cancer MCF-7 cells. Tumour Biol 2012; 33:2307 - 15; http://dx.doi.org/10.1007/s13277-012-0493-1; PMID: 22941467
   PubMed Web of Science ®Google Scholar
• Beutheu Youmba S, Belmonte L, Galas L, Boukhettala N, Bôle-Feysot C, Déchelotte P, Coëffier M. Methotrexate modulates tight junctions through NF-κB, MEK, and JNK pathways. J Pediatr Gastroenterol Nutr 2012; 54:463 - 70; http://dx.doi.org/10.1097/MPG.0b013e318247240d; PMID: 22197938
   PubMed Web of Science ®Google Scholar
• Hamada K, Shitara Y, Sekine S, Horie T. Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats. Cancer Chemother Pharmacol 2010; 66:1031 - 8; http://dx.doi.org/10.1007/s00280-010-1253-9; PMID: 20119715
   PubMed Web of Science ®Google Scholar
• Al-Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol 2008; 180:5653 - 61; PMID: 18390750
   PubMed Web of Science ®Google Scholar
• Mullin JM, Snock KV. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 1990; 50:2172 - 6; PMID: 2180562
   PubMed Web of Science ®Google Scholar
• Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 2005; 166:409 - 19; http://dx.doi.org/10.1016/S0002-9440(10)62264-X; PMID: 15681825
   PubMed Web of Science ®Google Scholar
• Casas E, Barron C, Francis SA, McCormack JM, McCarthy KM, Schneeberger EE, Lynch RD. Cholesterol efflux stimulates metalloproteinase-mediated cleavage of occludin and release of extracellular membrane particles containing its C-terminal fragments. Exp Cell Res 2010; 316:353 - 65; http://dx.doi.org/10.1016/j.yexcr.2009.10.020; PMID: 19854171
   PubMed Web of Science ®Google Scholar
• Beauchesne E, Desjardins P, Hazell AS, Butterworth RF. Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficient mouse brain. Neurochem Int 2009; 55:275 - 81; http://dx.doi.org/10.1016/j.neuint.2009.03.014; PMID: 19576514
   PubMed Web of Science ®Google Scholar
• Lischper M, Beuck S, Thanabalasundaram G, Pieper C, Galla HJ. Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions. Brain Res 2010; 1326:114 - 27; http://dx.doi.org/10.1016/j.brainres.2010.02.054; PMID: 20197061
   PubMed Web of Science ®Google Scholar
• Bauer AT, Bürgers HF, Rabie T, Marti HH. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 2010; 30:837 - 48; http://dx.doi.org/10.1038/jcbfm.2009.248; PMID: 19997118
   PubMed Web of Science ®Google Scholar
• Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S. Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 1997; 137:1393 - 401; http://dx.doi.org/10.1083/jcb.137.6.1393; PMID: 9182670
   PubMed Web of Science ®Google Scholar
• Council NHMRC. Australian code of practice for the care and use of animals for scientific purposes. Canberra: National Health and Medical Research Council, 2004.
   Google Scholar
• Gibson RJ, Bowen JM, Alvarez E, Finnie J, Keefe DM. Establishment of a single-dose irinotecan model of gastrointestinal mucositis. Chemotherapy 2007; 53:360 - 9; http://dx.doi.org/10.1159/000107458; PMID: 17713326
   PubMed Web of Science ®Google Scholar
• Gibson RJ, Keefe DM, Clarke JM, Regester GO, Thompson FM, Goland GJ, Edwards BG, Cummins AG. The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemother Pharmacol 2002; 50:53 - 8; http://dx.doi.org/10.1007/s00280-002-0460-4; PMID: 12111112
   PubMed Web of Science ®Google Scholar
• Gibson RJ, Keefe DM, Thompson FM, Clarke JM, Goland GJ, Cummins AG. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig Dis Sci 2002; 47:2751 - 7; http://dx.doi.org/10.1023/A:1021061306913; PMID: 12498296
   PubMed Web of Science ®Google Scholar
• Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DM. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 2003; 18:1095 - 100; http://dx.doi.org/10.1046/j.1440-1746.2003.03136.x; PMID: 12911669
   PubMed Web of Science ®Google Scholar
• Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DM. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol 2008; 62:33 - 41; http://dx.doi.org/10.1007/s00280-007-0570-0; PMID: 17703303
   PubMed Web of Science ®Google Scholar
• Al-Dasooqi N, Bowen JM, Gibson RJ, Logan RM, Stringer AM, Keefe DM. Selection of housekeeping genes for gene expression studies in a rat model of irinotecan-induced mucositis. Chemotherapy 2011; 57:43 - 53; http://dx.doi.org/10.1159/000321477; PMID: 21282945
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402 - 8; http://dx.doi.org/10.1006/meth.2001.1262; PMID: 11846609
   PubMed Web of Science ®Google Scholar
• Bowen JM, Gibson RJ, Keefe DM, Cummins AG. Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans. Pathology 2005; 37:56 - 62; http://dx.doi.org/10.1080/00313020400023461; PMID: 15875735
   PubMed Web of Science ®Google Scholar